One in every three dogs gets cancer, according to the National Canine Cancer Foundation. OneHealth, a startup that just raised a $5 million seed round led by Andreessen Horowitz’s Bio fund with participation from Lerer Hippeau and Y Combinator,aims to make it easier for humans to treat canine cancer, which is the number one disease killer of pups.
“Prevalence and incidence for cancer is much higher with dogs,” OneHealth founder and CEO Christina Lopes told TechCrunch over the phone.
OneHealth’s Fidocure product is designed to make treating your dog’s cancer more accessible and affordable. It specifically utilizes next-generation gene sequencing to better understand the genetic mutation that is causing an individual dog’s cancer. From there, Fidocare offers recommendations and an action plan to the human, outlining the best therapeutic implications and targeted treatment. …continue reading this story on Vector News